Akèy › Kansè nan tete › Illinois › Cicero
Etid klinik pou Kansè nan tete nan Cicero, IL
11 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Cicero (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Ap rekriteFaz 3
- Hope And Healing Care, Hinsdale · 10 mi lwen
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- OSF Little Company of Mary Medical Center, Evergreen Park · 9 mi lwen
- Advocate Christ Medical Center, Oak Lawn · 9 mi lwen
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Ap rekriteFaz 3
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mi lwen
- Loyola University Medical Center, Maywood · 5 mi lwen
- Marjorie Weinberg Cancer Center at Loyola-Gottlieb, Melrose Park · 7 mi lwen
- ak 6 plis
E-Mindfulness Approaches for Living After Breast Cancer
Ap rekriteFaz 3
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mi lwen
- Loyola University Medical Center, Maywood · 5 mi lwen
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi lwen
- ak 1 plis
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Ap rekriteFaz 2
- Loyola University, Maywood · 5 mi lwen
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Ap rekriteFaz 3
- Loyola University Medical Center, Maywood · 5 mi lwen
- Advocate Christ Medical Center, Oak Lawn · 9 mi lwen
- Elmhurst Memorial Hospital, Elmhurst · 10 mi lwen
- ak 1 plis
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
Ap rekriteFaz 1/2
- Hope and Healing Cancer Services, Hinsdale · 10 mi lwen
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Ap rekriteEtid obsèvasyon
- Advocate Christ Medical Center, Oak Lawn · 9 mi lwen
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9 mi lwen
- Advocate High Tech Medical Park, Palos Heights · 12 mi lwen
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Ap rekriteFaz 3
- Loyola University Medical Center, Maywood · 5 mi lwen
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Ap rekriteEtid obsèvasyon
- Affiliated Oncologists, Oak Lawn · 9 mi lwen
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
Ap rekrite
- Loyola University, Maywood · 5 mi lwen
Etid Kansè nan tete nan lòt vil
- New York City, NY134 etid
- Houston, TX126 etid
- Boston, MA111 etid
- Nashville, TN80 etid
- Los Angeles, CA72 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Durham, NC63 etid
- Queens, NY63 etid
- Chicago, IL58 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan Cicero
- Kansè Poumon ki pa ti selil24 etid
- Kansè poumon17 etid
- Kansè pwostat14 etid
- Kansè (tout kalite)13 etid
- Leksemi mieloïd egi11 etid
- Kansè kolorektal10 etid
- Kansè vejik8 etid
- Kansè Metastatik7 etid
- Melanom7 etid
- Maladi kadyovaskilè7 etid
- Limfòm Burkitt6 etid
- Karsinòm selil skuamèz tèt ak kou6 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.